Azenta Life Sciences
Azenta Life Sciences is committed to helping customers reach new heights in their pursuit of scientific progress. Discover enterprise-wide sample exploration and management solutions to accelerate discovery, development and delivery, with greater speed and precision. Azenta Life Sciences strive to keep elevating each other, their customers’ work and their industry – building a healthier world for people everywhere.
Latest News and Features
Industry Insight
Addressing Growing ULT Storage Demands With More Efficient, Automated, Sustainable Solutions
In this article, Cristiana Bercea discusses how large, automated storage solutions are helping companies to save time, unlock greater efficiency and better meet sustainability goals – without increasing risk.
Industry Insight
Automating the Future of Biobanking
UK Biocentre is adopting Azenta’s BioArc™ Ultra™, an automated -80°C storage system, to enhance biobanking efficiency and sustainability. With high-density storage and precise temperature control, it safeguards valuable samples.
Industry Insight
Biobanking Quality Management Systems and Best Practices
As we discussed in our last post, the Role of Biobanking in Protecting Sample Chain of Custody, biobanks serve as biospecimen libraries as well as sample data, validation, and reference sources for both research and clinical labs.
Industry Insight
Role of Biobanking in Protecting Sample Chain of Custody
This blog series will examine current and foreseen challenges for biobanks, as well as the systems and practices that mitigate these challenges.
Article
Overcoming Obstacles in Automating Cryogenic Storage
This article explores the challenges and strategies involved in transitioning to automated cryogenic storage systems. From assessing current infrastructure to gaining organizational buy-in and selecting appropriate containers, follow these steps to help ensure a successful transition to automated cryogenic storage.
Industry Insight
Addressing RNA Research Challenges
In this interview, we hear from Dr. Eliza Small about the current challenges facing RNA therapeutic development and how these challenges can be overcome.
Advertisement